SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-074450
Filing Date
2023-06-26
Accepted
2023-06-26 06:07:55
Documents
13
Period of Report
2023-06-22
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2319533d1_8k.htm   iXBRL 8-K 41930
2 EXHIBIT 3.1 tm2319533d1_ex3-1.htm EX-3.1 129597
  Complete submission text file 0001104659-23-074450.txt   380077

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA nxtc-20230622.xsd EX-101.SCH 3227
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE nxtc-20230622_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nxtc-20230622_pre.xml EX-101.PRE 22359
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2319533d1_8k_htm.xml XML 3829
Mailing Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705
Business Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705 240-399-4900
NextCure, Inc. (Filer) CIK: 0001661059 (see all company filings)

IRS No.: 475231247 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38905 | Film No.: 231039348
SIC: 2834 Pharmaceutical Preparations